Jaundice
Understanding jaundice diagnosis, symptoms, and treatment. Find information on hyperbilirubinemia, neonatal jaundice, obstructive jaundice, and other related conditions. Explore clinical documentation requirements, ICD-10 codes (R17), medical billing guidelines, and differential diagnoses for jaundice. Learn about laboratory tests, including bilirubin levels, and effective management strategies for patients with jaundice. This resource provides valuable information for healthcare professionals, medical coders, and individuals seeking to understand this condition.
Yellowing of skin and eyes due to high bilirubin levels.
Yellow skin, scleral icterus, dark urine, pale stools, itching.
Newborns, liver disease, gallbladder problems, blood disorders.
ICD-10 Code Families
Complete code families applicable to R17
When to use each related code
| Description | When to use |
|---|---|
| Yellowing of skin/eyes | Visible yellow discoloration of skin, sclera, or mucous membranes due to bilirubin buildup. |
| Neonatal jaundice | Yellowing of skin in newborns within first 2-4 weeks of life, often physiological. |
| Obstructive jaundice | Jaundice caused by blockage in bile duct, leading to impaired bile flow. Consider gallstones, tumors. |
Best-practice checklist
- ✓Jaundice onset date
- ✓Specific jaundice type (neonatal, obstructive, etc.)
- ✓Underlying cause if known (e.g., hepatitis, gallstones)
- ✓Bilirubin levels (total and direct)
- ✓Physical exam findings (e.g., scleral icterus, skin color)
Common pitfalls to avoid
Coding jaundice without specifying neonatal, obstructive, or other types leads to inaccurate DRG assignment and lost revenue.
Failing to code the underlying condition causing jaundice (e.g., hepatitis, gallstones) impacts risk adjustment and quality metrics.
Missing kernicterus (bilirubin encephalopathy) in neonatal jaundice cases leads to underreporting of severity and potential medical necessity issues.
Best-practice tips
- 01Document bilirubin levels, location, onset for accurate ICD-10 coding.
- 02Specify jaundice type (neonatal, obstructive, etc.) for optimal reimbursement.
- 03Query physician for cause of jaundice to improve CDI and HCC coding.
- 04Review lab results (liver function tests) for complete clinical picture.
- 05Ensure documentation supports medical necessity for compliance.
Step-by-step checklist
- 1
Confirm visible jaundice: skin, sclera
- 2
Review bilirubin levels: total, direct
- 3
Assess liver function tests: ALT, AST, ALP
- 4
Evaluate for hemolysis: CBC, haptoglobin
- 5
Consider imaging if indicated: ultrasound, CT
Ready-to-paste narrative
Patient presents with jaundice, characterized by yellowing of the skin and sclera. Differential diagnosis includes neonatal jaundice, obstructive jaundice, hemolytic jaundice, and hepatocellular jaundice. Assessment focuses on identifying the underlying etiology, considering risk factors such as age, medication history including acetaminophen and statins, family history of liver disease, alcohol consumption, recent infections like hepatitis, and exposure to toxins. Physical examination reveals icterus, and may include hepatomegaly, splenomegaly, or abdominal tenderness. Laboratory tests, including total bilirubin, direct bilirubin, indirect bilirubin, liver function tests (LFTs) such as AST, ALT, ALP, and GGT, complete blood count (CBC), and coagulation studies, are essential for diagnosis and monitoring. Imaging studies, like abdominal ultrasound, CT scan, or MRI, may be indicated to evaluate liver and biliary tract anatomy. Treatment for jaundice depends on the underlying cause and may include phototherapy for neonatal jaundice, endoscopic retrograde cholangiopancreatography (ERCP) for biliary obstruction, or medications to manage underlying liver disease. Patient education regarding lifestyle modifications, dietary restrictions, and medication adherence is crucial. ICD-10 codes for jaundice may include R17 (jaundice, unspecified), R18 (other jaundice), or more specific codes based on the underlying cause. CPT codes for diagnostic and treatment procedures will be documented based on services rendered. Follow-up is essential to monitor bilirubin levels, liver function, and treatment response.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.